Roche Holding AG
(OTCPK:RHHBY)
$
41.71
0.28 (0.68%)
Market Cap: 265.87 Bil
Enterprise Value: 300.73 Bil
PE Ratio: 21.39
PB Ratio: 7.80
GF Score: 90/100 Roche Holding AG (RHHBY) Transcripts
- Half Year 2024 Roche Holding AG Earnings Call TranscriptJul 25, 2024$39.56 (+2.65%)Earnings
- Lonza Group AG Signs Agreement to Acquire Large-Scale Biologics Site in Vacaville (US) from Roche Holding AG Call TranscriptMar 20, 2024
- Roche Holding AG Neurology Update TranscriptMar 11, 2024
- Full Year 2023 Roche Holding AG Earnings Presentation TranscriptFeb 01, 2024
- Roche Holding AG Neuroscience Update IR Event TranscriptOct 30, 2023
- Q3 2023 Roche Holding AG Corporate Sales Presentation TranscriptOct 19, 2023
- Roche Holding AG Pharma Day TranscriptSep 11, 2023
- Half Year 2023 Roche Holding AG Earnings Call TranscriptJul 27, 2023$38.87 (-0.72%)Earnings
- Alnylam Pharmaceuticals Inc to Discuss Collaboration with Roche TranscriptJul 24, 2023
- Roche Holding AG Virtual EHA 2023 Event: Crovalimab in Hematology and Nephrology TranscriptJun 12, 2023
- Roche Holding AG Virtual ESG Event TranscriptMay 23, 2023
- Q1 2023 Roche Holding AG Corporate Sales Call TranscriptApr 26, 2023
- Roche Holding AG Virtual Event - Update following Angiogenesis TranscriptFeb 13, 2023
- Full Year 2022 Roche Holding AG Earnings Call TranscriptFeb 02, 2023$37.66 (-1.72%)Earnings
- Roche Holding AG ASH Medical Congress Virtual Event TranscriptDec 14, 2022
- Q3 2022 Roche Holding AG Corporate Sales Presentation TranscriptOct 18, 2022
- Roche Holding AG Pharma Day 2022 TranscriptSep 12, 2022
- Half Year 2022 Roche Holding AG Earnings Call TranscriptJul 21, 2022$41.96 (-0.52%)Earnings
- Roche Holding AG Virtual Event at the 2022 ASCO Annual Meeting Focusing on the Oncology Pipeline TranscriptJun 06, 2022
- Roche Holding AG Virtual ESG Event: Access to Healthcare TranscriptMay 16, 2022
- Q1 2022 Roche Holding AG Corporate Sales Call TranscriptApr 25, 2022
- Roche Holding AG Annual Shareholders Meeting TranscriptMar 15, 2022
- Roche Holding AG Virtual Event on Key Ophthalmology Data Presented at the Angiogenesis 2022 Meeting TranscriptFeb 14, 2022
- Full Year 2021 Roche Holding AG Earnings Presentation TranscriptFeb 03, 2022
- Roche Holding AG ASH Virtual Update Event TranscriptDec 15, 2021
- Roche Holding AG Virtual Analyst Event During ESMO IO TranscriptDec 10, 2021
- Roche Holding AG Virtual Event "Digitalization Along the Value Chain" TranscriptNov 17, 2021
- Q3 2021 Roche Holding AG Corporate Sales Call TranscriptOct 20, 2021
- Roche Holding AG Pharma Day (Virtual) TranscriptSep 14, 2021
- Half Year 2021 Roche Holding AG Earnings Presentation TranscriptJul 22, 2021
- Roche Holding AG Virtual Event on Key Evrysdi Data Presented at 2021 CureSMA Annual Meeting TranscriptJun 14, 2021
- Roche Holding AG Virtual Event on Key Oncology Data Presented at 2021 ASCO Annual Meeting TranscriptJun 08, 2021
- Q1 2021 Roche Holding AG Corporate Sales Call TranscriptApr 21, 2021
- Roche Holding AG Diagnostics Investor Day (Virtual) TranscriptMar 23, 2021
- Roche Holding AG Virtual Event on Key Data Presented at the 2021 MDA Virtual Clinical & Scientific Conference TranscriptMar 19, 2021
- Roche Holding AG Virtual Event on Key Ophthalmology Data Presented at the Angiogenesis 2021 Meeting TranscriptFeb 16, 2021
- Full Year 2020 Roche Holding AG Earnings Presentation TranscriptFeb 04, 2021
- Roche Holding AG Virtual Event on Key Hematology Data Presented at ASH 2020 TranscriptDec 08, 2020
- Q3 2020 Roche Holding AG Corporate Sales Call TranscriptOct 15, 2020
- Roche Holding AG Virtual Pharma Day TranscriptSep 14, 2020
- Roche Holding AG Virtual Event on Data Presented at American Society of Retina Specialists 38th Annual Meeting TranscriptJul 27, 2020
- Half Year 2020 Roche Holding AG Earnings Call TranscriptJul 23, 2020$44.03 (-5.21%)Earnings
- Roche Holding AG Key Oncology Data Presented at ASCO 2020 (Virtual) TranscriptMay 29, 2020
- Roche Holding AG at UBS Global Healthcare Conference (Virtual) TranscriptMay 19, 2020
- Roche Holding AG Virtual Digital Technology and Advanced Analytics Event TranscriptMay 07, 2020
- Roche Holding AG to Discuss New AAN 2020 Data Call TranscriptApr 28, 2020
- Q1 2020 Roche Holding AG Corporate Sales Call TranscriptApr 22, 2020
- Roche Holding AG Virtual Early Drug Development gRED Call TranscriptFeb 18, 2020
- Roche Holding AG Efficacy and Safety of Risdiplam in Patients with Type 2/3 Spinal Muscular Atrophy Presented at SMA Europe 2020 Call TranscriptFeb 06, 2020
- Full Year 2019 Roche Holding AG Earnings Call TranscriptJan 30, 2020$42.51 (+2.51%)Earnings
- Roche Holding AG, Bristol-Myers Squibb Co and PhRMA at JPMorgan Healthcare Conference - Panel Session TranscriptJan 15, 2020
- Sarepta Therapeutics Inc to Discuss Partnership with Roche Holding AG for its Investigational Micro-dystrophin Gene Therapy for Duchenne Muscular Dystrophy Call TranscriptDec 23, 2019
- Roche Holding AG to Discuss Key Data Presented at SABCS 2019 TranscriptDec 16, 2019
- Roche Holding AG to Discuss Key Hematology Data Presented at ASH 2019 TranscriptDec 10, 2019
- Roche Holding AG to Discuss Gazyva in Lupus Nephritis Presented at ASN/ASR 2019 TranscriptNov 12, 2019
- Roche Holding AG Virtual Early Drug Development pRED Event Call TranscriptNov 11, 2019
- Q3 2019 Roche Holding AG Corporate Sales Call TranscriptOct 16, 2019
- Roche Holding AG Pharma Day TranscriptSep 16, 2019
- Half Year 2019 Roche Holding AG Earnings Call TranscriptJul 25, 2019$33.27 (-1.92%)Earnings
- Roche Holding AG Analyst Event at ASCO 2019 TranscriptJun 03, 2019
- Roche Holding AG at American Academy of Neurology Annual Meeting TranscriptMay 13, 2019
- Q1 2019 Roche Holding AG Corporate Sales Call TranscriptApr 17, 2019
- 1